Bolt Biotherapeutics
BOLT
BOLT
40 hedge funds and large institutions have $32.4M invested in Bolt Biotherapeutics in 2023 Q1 according to their latest regulatory filings, with 4 funds opening new positions, 13 increasing their positions, 7 reducing their positions, and 8 closing their positions.
Holders
40
Holders Change
-4
Holders Change %
-9.09%
% of All Funds
0.64%
Holding in Top 10
2
Holding in Top 10 Change
+1
Holding in Top 10 Change %
+100%
% of All Funds
0.03%
New
4
Increased
13
Reduced
7
Closed
8
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–
Top Buyers
| 1 |
TCM
1
Tang Capital Management
San Diego,
California
|
$2.26M |
| 2 |
O
2
OrbiMed
New York
|
$2.14M |
| 3 |
3
Adage Capital Partners
Boston,
Massachusetts
|
$695K |
| 4 |
4
Morgan Stanley
New York
|
$426K |
| 5 |
5
JPMorgan Chase & Co
New York
|
$263K |
